MIP1A/CCL3 and eotaxin/CCL11 are linked to AD (64, 71–73), MCP1/CCL2 levels correlate with neuroinflammation, brain atrophy, and cognitive decline in AD (74–76), and MCP3/CCL7 is part of a diagnostic panel for AD (77). Here, CCL11 is linked to Brain atrophy.